Amylyx Pharmaceuticals, Inc. Common Stock (AMLX)
Market Closed
16 Oct, 08:00 PM
NASDAQ (NGS) NASDAQ (NGS) Primary $
26. 34
-1.31
-4.7378%
$
3.13B Market Cap
- P/E Ratio
- Div Yield
1.15M Volume
- Eps
$ 27.65
Previous Close 
Want to track AMLX and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Amylyx Pharmaceuticals, Inc. Common Stock (AMLX) Statistics
Valuation metrics
Market Cap 3.13B
Enterprise value 3.08B
Trailing P/E (ttm) -19.96
Forward P/E -
PEG ratio -0.34
Price/Sales (ttm) -
Price/Book (mrq) 13.08
Enterprise Value/Revenue -
Enterprise Value/EBITDA -20.59
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 1.41M
Average volume (90 days) 1.69M
Price summary
52-Week low 10.83
52-Week high 41.14
Beta -
50-Day moving average 29.75
200-Day moving average 16.87
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -
Operating margin -
Operational effectiveness
Return on assets -0.57%
Return on equity -0.53%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) -
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -1.37
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 2.26
Total debt (mrq) -
Total Debt/Equity (mrq) 0.02
Current ratio (mrq) 12.12%
Book value per share (mrq) 2.15
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
2026 © Marketlog. All Rights Reserved.
